Stock ALVAL VALBIOTIS
Add to a list
To use this feature you must be a member
Log inSign up

Insiders VALBIOTIS

Equities

ALVAL

FR0013254851

Market Closed - Euronext Paris
Other stock markets
 11:35:07 2024-05-03 am EDT 		5-day change 1st Jan Change
4.13 EUR +0.49% Intraday chart for VALBIOTIS +5.90% -17.40%
Apr. 26 Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 03 Valbiotis: launch of Valbiotis PRO Cholesterol in May CF

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Valbiotis Appoints Frédéric PELONG to Board of Directors
CI
Valbiotis CFO To Step Down In June
MT
Valbiotis Announces Board of Directors Changes
CI
Valbiotis Appoints Sébastien Bessy as Chief Operating Marketing and Business Officer
CI
VALBIOTIS Appoints Agnès TIXIER to the Supervisory Board
CI
VALBIOTIS Names Murielle Cazaubiel as Director of Development and Medical Affairs
CI
Valbiotis Appoints Josep Infesta, International Expert in Consumer Healthcare, Head of Global Business Development
CI
VALBIOTIS Announces the Appointment of Murielle Cazaubiel as Director of Development and Medical Affairs
CI
VALBIOTIS Appoints Pascal Sirvent to its Board of Directors
CI
VALBIOTIS Appoints Cécile Merle to the Position of Quality Assurance Director
CI
Valbiotis Appoints Christine Roy-Duval as Director of Development and Medical Affairs
CI
VALBIOTIS Appoints Jean Zetlaoui on Valbiotis to Supervisory Board
CI
VALBIOTIS: Pascal SIRVENT Appointed Director of Discovery and Preclinical Research
BU
Valbiotis SA Appoints Pascal SIRVENT as Director of Discovery and Preclinical Research
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALVAL Stock
  4. News VALBIOTIS
  5. Insiders